Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NTP Radioisotopes Europe is a specialized supplier and distributor of medical radioisotopes and radiopharmaceuticals serving the European healthcare sector. As the European subsidiary of the South African NTP Radioisotopes SOC Ltd, the company provides a reliable supply of essential isotopes such as Molybdenum-99, Iodine-131, and Lutetium-177. These materials are fundamental to nuclear medicine, supporting both diagnostic imaging procedures and targeted radionuclide therapies for various cancers. Based in Belgium, the company plays a critical role in the global radiopharmaceutical supply chain, ensuring that time-sensitive radioactive products reach hospitals and clinics efficiently. Their portfolio enables advanced treatments for neuroendocrine tumors and prostate cancer, as well as diagnostic scans for millions of patients annually.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NTP Radioisotopes Europe.